Mission
To pool the intellectual and scientific resources of member institutions to further research and discovery in cancer prevention, treatment strategies, and palliative care.
The American Eurasian Cancer Alliance (AECA) was developed through Fox Chase Cancer Center in 2001 to represent a unique international scientific partnership. In 2004, AECA became affiliated with the U.S. National Cancer Institute’s Office of International Affairs to function as the primary driver of scientific exchange between the U.S. and Eurasian research centers. As NCI reprioritized their international efforts with the formation of the Center for Global Health in 2011, AECA remained an engaged partner and major contributor to the development of cancer control, research, and palliative care initiatives within the Eurasian region.
AECA’s programs focus on three main areas:
Strengthening Global Cancer Research
Promoting Research Training and Education
Translating Research into Policy and Programs
Impact
AECA accelerates the development of international partnerships, ensuring the timely completion of sustainable initiatives and advancements in cancer research and public policy through continued engagement in the region.
Bilateral Research Collaboration
Radio-immunotherapy
Tobacco Control
Cancer Control
Current Initiatives
AECA Leadership
Executive Director Dr. Sophia Michaelson
Dr. Sophia Michaelson is the Executive Director of the American Eurasian Cancer Alliance (AECA). With over 25 years of experience in project management and partnership development, she manages large, complex international health projects from inception to implementation. Her efforts have propelled organizations to create sustainable programs which both contribute to global cancer control efforts and advance domestic research agendas.
Dr. Michaelson has a distinctive record of structuring teams and programs that promote international collaboration in cancer research. Her deep understanding of the global health landscape spans across health policy, clinical research, and program development arenas. She provides turnkey solutions for scientific leaders, government officials and private sector stakeholders in efforts to develop sustainable international health programs throughout the Eurasian region.
With a multicultural and multilingual background, Dr. Michaelson has received advanced degrees from institutions within the United States and Eurasian region. With an educational and professional background in international health and government affairs, as part of Venturefind Enterprises Medical she serves as a critical resource in the development of academic and government-led programs and partnerships that produce innovative research and cancer control initiatives.
Dr. Otis Brawley
Dr. Otis Brawley is a globally-recognized expert in cancer prevention and control. He has worked to reduce overscreening of medical conditions, which has revolutionized patient treatment by increasing quality of life and reducing health disparities.
Dr. Brawley is the Associate Director of Community Outreach and Engagement at the Sidney Kimmel Comprehensive Cancer Center and a Professor of Oncology at the Bloomberg School of Public Health. Dr. Brawley will provide public health oversight to AECA-led international health programs and policies.
Chief Medical Officers
Professor, Wake Forest University School of Medicine
Division Director, Levine Cancer Institute at Atrium Health Wake Forest University Comprehensive Cancer Center
Professor, Wake Forest University School of Medicine
Director of Research, Levine Cancer Institute at Atrium Health Wake Forest University Comprehensive Cancer Center
Associate Director, Clinical Trials Office, Levine Cancer Institute at Atrium Health Wake Forest University Comprehensive Cancer Center
AECA Supporting Staff
Elena Voskoboynik, RN, Virtual Education Program Liaison
Laura Wagstaff, MPH, Executive Editor
Kate Safonova, Administrative Affairs & Graphic Design
Alexander Goldshtrakh, IT and Cybersecurity
Boris Gorlin, Linguistic Translator
Contact:
Learn more about the American Eurasian Cancer Alliance and our global cancer research and control capabilities.
